NEW YORK (Reuters Health) - The anti-psychotic drug trifluoperazine is well-tolerated and superior to inactive "placebo" in the short-term treatment of generalized anxiety disorder, a chronic disorder ...

Vraylar (cariprazine) is a powerful antipsychotic medication that is approved by the Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder, and major depressive disorder (MDD).

I never would have entered the DSM 5 controversy were it not for two of its proposals that risk furthering the already frightening overuse of antipsychotic medication, particularly in children and ...

A new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada between 2000 and 2022. It found that ...